Lv1
48 积分 2023-12-22 加入
DB-2304, a Duality Immune Modulating Antibody‒Drug Conjugate (DIMAC) targeting BDCA2, displays strong potency in the suppression of pDC functions
3个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
3个月前
已完结
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate
3个月前
已完结
Anti-TNF-α therapies: the next generation
3个月前
已完结
The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors
4个月前
已完结
Drug delivery with carbon nanotubes for in vivo cancer treatment
4个月前
已完结
Drug delivery with carbon nanotubes for in vivo cancer treatment
4个月前
已完结
ORM-6151: A First-in-Class, Anti-CD33 Antibody-Enabled GSPT1 Degrader for AML
4个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
4个月前
已完结
Endotoxin removal from protein solutions
6个月前
已完结
皖公网安备34019202002308
